---
document_datetime: 2025-10-30 09:48:53
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/zimbus-breezhaler-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: zimbus-breezhaler-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 5.0316679
conversion_datetime: 2025-12-28 11:24:56.32916
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Zimbus Breezhaler

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific informationafterauthorisation(archive).

| Applicationnumber   | Scope                       | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|-----------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| VariationtypeIA/    | A.ADMINISTRATIVECHANGES-A.7 | 28/10/2025                          |                                          | SmPC,                           |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000289953                     | Deletionofmanufacturingsitesfor an active substance, intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place,orsupplierofastartingmaterial, reagent or excipient (when mentioned in the dossier)* - Accepted B.IV.1 Change of a measuring or administration device-B.IV.1.bDeletion of a device - Accepted                                                                                                            |            | Labelling and PL   |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|--------------------|
| Variation type IA / EMA/VR/0000244523 | B.1.b.2 Change in test procedure for active substance or starting material/reagent/intermediateusedinthe manufacturingprocessof the active substance-B.I.b.2.aMinorchangestoan approvedtestprocedure-Accepted B.1.b.2 Change in testprocedureforactive substance or starting material/reagent/intermediateused in the manufacturingprocessoftheactive substance-B.I.b.2.a Minor changes to an approved test procedure-Accepted B.1.b.2 Change in test procedure for active substance or starting | 23/07/2025 |                    |

<div style=\"page-break-after: always\"></div>

A.ADMINISTRATIVECHANGES-A.7 Deletionofmanufacturingsitesfor an active substance, intermediate or finished product, packaging site, manufacturer responsible for batchrelease,sitewherebatchcontroltakes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)*- Accepted

## A.ADMINISTRATIVE CHANGES-A.7

Deletion ofmanufacturingsitesfor an active substance,intermediate orfinishedproduct, packagingsite,manufacturerresponsiblefor batchrelease,sitewherebatchcontrol takes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)*-Accepted

A. ADMINISTRATIVE CHANGES - A.4 Change in thename and/oraddressof:a manufacturer(includingwhererelevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, startingmaterial,reagentorintermediate used in the manufacture of the active substance (where specified in the technical dossier)wherenoPh.Eur.Certificateof Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier) - Accepted